There are well-established disparities in cancer incidence and outcomes by race/ethnicity
that result from the interplay between structural, socioeconomic, socio-environmental …

A systematic review to identify risk factors for prostate biopsy-related infection, preventative
strategies, and optimal management of infectious complications was conducted. Significant …

Background Gleason scores from standard, 12-core prostate biopsies are upgraded
historically in 25− 33% of patients. Multiparametric prostate magnetic resonance imaging …

Background Prostate biopsy guided by computer-assisted fusion of magnetic resonance
imaging (MRI) and transrectal ultrasound (TRUS) images (MRI group) has not yet been …

Background An approach based on multiparametric magnetic resonance imaging (mpMRI)
might increase the detection rate (DR) of clinically significant prostate cancer (csPCa) …

Objectives To assess whether the proportion of men with clinically significant prostate
cancer (PCa) is higher among men randomized to multiparametric magnetic resonance …

Image-guided percutaneous needle biopsy (PNB) has proven to be a safe and effective
procedure, and it became a common procedure representing an essential step for diagnosis …

Prostate cancer is a paradigm tumor model for heterogeneity in almost every sense. Its
clinical, spatial, and morphological heterogeneity divided by the high-level molecular …

Prostate cancer (PCa) is the most frequently diagnosed cancer and the second leading
cause of cancer death among men in Western countries. Current screening techniques are …

Background Knowledge of significant prostate (sPCa) locations being missed with magnetic
resonance (MR)-and transrectal ultrasound (TRUS)-guided biopsy (Bx) may help to improve …